Vinehealth Valuation Estimate
Vinehealth Valuation as of Last Funding Round
Vinehealth Company Overview
Vinehealth provides a simple way for people undergoing treatment for cancer to track their health and well-being indicators and share the information with their clinicians. They are trusted by the NHS, Cyber Essentials, and the General Data Protection Regulation from the EU. They have raised $5.5 million of investment in their latest seed funding round at the end of 2023, led by Talis Capital, and participation from investors such as Playfair Capital and Ascension.
Vinehealth Valuation History
Vinehealth Stock Price
The stock price of Vinehealth can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Vinehealth has issued 250 million shares, at the estimated UpMarket valuation of $20.97 million, each share of Vinehealth stock would be worth $0.08.
Buy Vinehealth Stock
If you would like to buy shares in Vinehealth, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Vinehealth stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Vinehealth as well.
Vinehealth Management
Name | Position |
---|---|
Rayna Patel | CEO |
Georgina Kirby | CTO |